Authors
Simon E Melchior, Liv B Schöps, Jeppe K Petersen, Christian L Carranza, Lars Køber, Emil L Fosbøl, Lauge Østergaard
Published in
European heart journal. Valvular and structural heart disease. Volume 2. Issue 3. Pages xwag076. Epub Aug 26, 2026.
Abstract
Loop diuretic use (LDU) may provide complementary information on post-operative heart failure (HF) burden after mitral valve surgery (MVS).
We investigated changes in LDU before and after MVS for mitral regurgitation (MR) and assessed post-operative HF admission according to age.
Using Danish nationwide registries, we identified patients aged ≥18 years discharged after first-time MVS for MR between 1996 and 2022. LDU was assessed from redeemed prescriptions before surgery and at post-operative landmarks. HF admission within 5 years was estimated with death as a competing risk. Among 6840 patients, LDU was 46.2% before surgery and declined among survivors to 27.0% at 12-15 months and 23.7% at 36-39 months. Pre-operative use was more frequent with increasing age, ranging from 27.9% in patients aged 18-49 years to 64.3% in those aged ≥80 years. Postoperatively, LDU remained common, ranging from 13.5% to 41.6% at 12-15 months and from 11.9% to 35.4% at 36-39 months across age groups. The 5-year cumulative incidence of HF admission was 20.9% (95% CI: 20.0-22.0%) overall and increased across age groups, from 13.9% to 27.4%. Pre-operative LDU was associated with higher 5-year mortality irrespective of recorded HF status.
LDU declined after MVS for MR but remained common, particularly among older patients, and showed an age-related pattern consistent with hospital admission for HF.
PMID:
43053869
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0